Last reviewed · How we verify
PIKA rabies vaccine
At a glance
| Generic name | PIKA rabies vaccine |
|---|---|
| Also known as | 'PIKA rabies vaccine with PIKA adjuvant, PIKA rabies vaccine with PIKA adjuvant |
| Sponsor | Yisheng Biopharma (Singapore) Pte. Ltd. |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Study to Evaluate a PIKA Rabies Vaccine（Vero Cell）for Human Use,Freeze-dried (PHASE3)
- Efficacy and Safety of a PIKA Rabies Vaccine Containing the PIKA Adjuvant With an Accelerated Regimen (PHASE2)
- Safety and Efficacy of a PIKA Rabies Vaccine Containing the PIKA Adjuvant (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- PIKA rabies vaccine CI brief — competitive landscape report
- PIKA rabies vaccine updates RSS · CI watch RSS
- Yisheng Biopharma (Singapore) Pte. Ltd. portfolio CI